Get started
Silo Pharma, Inc.Silo Pharma, Inc.Silo Pharma, Inc.

Silo Pharma, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

SILO chart

Upcoming earnings

Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪5.37 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.21USD
Net income (FY)
‪−3.70 M‬USD
Revenue (FY)
‪72.10 K‬USD
Shares float
‪2.55 M‬
Beta (1Y)
1.33

About Silo Pharma, Inc.

Sector
Health Technology
CEO
Eric Weisblum
Headquarters
Sarasota
Website
silopharma.com
Employees (FY)
3
Founded
2010
FIGI
BBG002D1DZ06
Silo Pharma, Inc. is a developmental stage biopharmaceutical company, which engages in the merging of traditional therapeutics with psychedelic research. It seeks to acquire and develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs. The company was founded by Eric Weisblum on July 13, 2010 and is headquartered in Sarasota, FL.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SILO is 1.91 USD — it has increased by 3.93% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Silo Pharma, Inc. stocks are traded under the ticker SILO.
Silo Pharma, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
SILO stock is 9.01% volatile and has beta coefficient of 1.33. Check out the list of the most volatile stocks — is Silo Pharma, Inc. there?
Silo Pharma, Inc. revenue for the last quarter amounts to ‪18.00 K‬ USD despite the estimated figure of ‪18.00 K‬ USD. In the next quarter revenue is expected to reach ‪18.00 K‬ USD.
Yes, you can track Silo Pharma, Inc. financials in yearly and quarterly reports right on TradingView.
SILO stock has risen by 17.18% compared to the previous week, the month change is a 0.53% rise, over the last year Silo Pharma, Inc. has showed a 10.33% decrease.
SILO net income for the last quarter is ‪−1.12 M‬ USD, while the quarter before that showed ‪−660.16 K‬ USD of net income which accounts for −69.83% change. Track more Silo Pharma, Inc. financial stats to get the full picture.
Today Silo Pharma, Inc. has the market capitalization of ‪5.23 M‬, it has increased by 2.58% over the last week.
No, SILO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SILO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Silo Pharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
SILO reached its all-time high on Sep 24, 2014 with the price of 125.00 USD, and its all-time low was 1.22 USD and was reached on Oct 16, 2023.
See other stocks reaching their highest and lowest prices.
As of May 1, 2024, the company has 3.00 employees. See our rating of the largest employees — is Silo Pharma, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Silo Pharma, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Silo Pharma, Inc. stock shows the sell signal. See more of Silo Pharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Silo Pharma, Inc. EBITDA is ‪−3.86 M‬ USD, and current EBITDA margin is ‪−5.35 K‬%. See more stats in Silo Pharma, Inc. financial statements.